Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: BANCHEE who wrote (18849)	1/18/2000 11:18:00 AM
From: carepedeum2000	Read Replies (1) \| Respond to of 57584

enmd just added to bull market biotech porfolio, they have good track record, worth checking out ps my market call is being "tested", why wont the market do what i tell it to do? geez

To: BANCHEE who wrote (18849)	1/18/2000 11:25:00 AM
From: Proton	Respond to of 57584

Re: XYBR I agree with your observations. The "sweet spot" in trading is when TA, psychology, and business case converge. I don't want anyone to think one should have waited until XYBR hit 12 to buy. Holding from the low single-digits is preferred. :-) However, I notice people asking Rande about entering a stock after an initial run. If the business case and psychology are still valid, a technical approach can support two tactics: 1. Trading around a core position (a tactic to which Rande and J.J. Cramer both adhere, BTW), and 2. Entering or adding to positions near important support levels. Noticing that XYBR is coming back into the twelves. Watch critical support at 12 (say, a stop at 11 3/4). I'll stop beating this horse now. :-) P. [edit] p.s. Just noticed the Newsbytes article. "Mainstream" should pick up on XYBR soon. Heaven help us if Time decides to put Forgs ("Ford Borgs") on the cover. Ask Jeff Bezos! :-)